AbboshC, BirkbakNJ, WilsonGA, et al. (2017) Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature, 545:446-451.
2.
AdalsteinssonVA, HaG, FreemanSS, ChoudhuryAD, et al. (2017) Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. Nat Commun, 8:1324.
3.
BettegowdaC, SausenM, LearyRJ, et al. (2014) Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med, 6:224ra24.
4.
ChaeYK, DavisAA, CarneiroBA, et al. (2016) Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA. Oncotarget, 7:65364-65373.
5.
CohenJD, LiL, WangY, et al. (2018) Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science, 359:926.
6.
CorcoranRB, ChabnerBA (2018) Application of cell-free DNA analysis to cancer treatment. N Engl J Med, 379:1754-1765.
7.
DiehlF, SchmidtK, ChotiMA, et al. (2008) Circulating mutant DNA to assess tumor dynamics. Nat Med, 14:985-990.
8.
FanHC, BlumenfeldYJ, ChitkaraU, et al. (2010) Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing. Clin Chem, 56:1279-1286.
9.
HeitzerE, HaqueIS, RobertsCES, SpeicherMR (2018) Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet.
10.
JainS, LinYS, SongW, SuYH (2019) Urine-based liquid biopsy for nonurological cancers. Genet Test Mol Biomarkers, 23: DOI:10.1089/gtmb.2018.0189.
11.
Jamal-HanjaniM, WilsonGA, McGranahanN, et al. (2017) Tracking the evolution of non-small-cell lung cancer. New Eng J Med, 376:2109-2121.
12.
KourouK, ExarchosTP, ExarchosKP, et al. (2015) Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J, 13:8-17.
13.
KudererNM, BurtonKA, BlauS, et al. (2017) Comparison of 2 commercially available next-generation sequencing platforms in oncology. JAMA Oncol, 3:996-998.
14.
LeonSA, ShapiroB, SklaroffDM, YarosMJ (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res, 37:646-650.
15.
MandelP, MetaisP (1948) Nucleic acids of plasma blood in humans [in French]. C R Seances Soc Biol Fil, 142:241-243.
16.
SchrockAB, PavlickD, KlempnerSJ, et al. (2018) Hybrid capture-based genomic profiling of circulating tumor DNA from patients with advanced cancers of the gastrointestinal tract or anus. Clin Cancer Res, 24:1881-1890.
17.
SuYH, WangM, BrennerDE, et al. (2004) Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer. J Mol Diagn, 6:101-107.
WangJ, JainS, ChenD, et al. (2018) Development and evaluation of novel statistical methods in urine biomarker-based hepatocellular carcinoma screening. Sci Rep, 8:3799.
